Title : A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.

Pub. Date : 2015 Oct

PMID : 25980448






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Clopidogrel angiotensin I converting enzyme Homo sapiens
2 Clopidogrel inhibits carboxylesterase 1 (CES1), the enzyme responsible for converting prodrug ACE inhibitors (such as ramipril and perindopril) to their active metabolites. Clopidogrel angiotensin I converting enzyme Homo sapiens
3 CONCLUSIONS: Following myocardial infarction, use of clopidogrel with ACE inhibitors activated by CES1 is not associated with an increased risk of adverse cardiovascular outcomes relative to lisinopril. Clopidogrel angiotensin I converting enzyme Homo sapiens
4 These findings suggest that the recently described drug interaction between clopidogrel and prodrug ACE inhibitors is of little clinical relevance. Clopidogrel angiotensin I converting enzyme Homo sapiens